Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
After finishing at $25.38 in the prior trading day, Pfizer Inc (NYSE: PFE) closed at $25.74, up 1.42%. In other words, the price has increased by $1.42 from its previous closing price. On the day, 36.95 million shares were traded. PFE stock price reached its highest trading level at $25.885 during the session, while it also had its lowest trading level at $25.375.
Ratios:
Our goal is to gain a better understanding of PFE by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.05 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.77. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 1.16. In the meantime, Its Debt-to-Equity ratio is 0.70 whereas as Long-Term Debt/Eq ratio is at 0.65.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on April 22, 2025, initiated with a Neutral rating and assigned the stock a target price of $24.
On November 15, 2024, Wolfe Research started tracking the stock assigning a Underperform rating and target price of $25.Wolfe Research initiated its Underperform rating on November 15, 2024, with a $25 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 23 ’25 when Dolsten Mikael bought 59,781 shares for $23.09 per share.
Dolsten Mikael bought 55,000 shares of PFE for $1,312,736 on May 05 ’25. On Mar 04 ’25, another insider, DAMICO JENNIFER B., who serves as the SVP & Controller of the company, sold 2,500 shares for $25.93 each. As a result, the insider received 64,825 and left with 11,850 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PFE now has a Market Capitalization of 146346065920 and an Enterprise Value of 195458072576. As of this moment, Pfizer’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.68, and their Forward P/E ratio for the next fiscal year is 8.19. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.29 while its Price-to-Book (P/B) ratio in mrq is 1.65. Its current Enterprise Value per Revenue stands at 3.062 whereas that against EBITDA is 7.976.
Stock Price History:
The Beta on a monthly basis for PFE is 0.50, which has changed by -0.109342575 over the last 52 weeks, in comparison to a change of 0.13054323 over the same period for the S&P500. Over the past 52 weeks, PFE has reached a high of $30.43, while it has fallen to a 52-week low of $20.92. The 50-Day Moving Average of the stock is 4.31%, while the 200-Day Moving Average is calculated to be 2.87%.
Shares Statistics:
The stock has traded on average 40.58M shares per day over the past 3-months and 35339010 shares per day over the last 10 days, according to various share statistics. A total of 5.68B shares are outstanding, with a floating share count of 5.68B. Insiders hold about 0.12% of the company’s shares, while institutions hold 66.95% stake in the company. Shares short for PFE as of 1753920000 were 107778211 with a Short Ratio of 2.66, compared to 1751241600 on 111909372. Therefore, it implies a Short% of Shares Outstanding of 107778211 and a Short% of Float of 1.9.
Dividends & Splits
In the trailing 12 months, PFE’s forward annual dividend rate was 1.7, compared to 1.71 this year. Against a Trailing Annual Dividend Yield of 0.06698188The stock’s 5-year Average Dividend Yield is 4.64. The current Payout Ratio is 119.94% for PFE, which recently paid a dividend on 2025-07-25 with an ex-dividend date of 2025-07-25. Stock splits for the company last occurred on 2020-11-17 when the company split stock in a 1054:1000 ratio.
Earnings Estimates
The current assessment of Pfizer Inc (PFE) involves the perspectives of 16.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.7, with high estimates of $0.83 and low estimates of $0.61.
Analysts are recommending an EPS of between $3.24 and $2.97 for the fiscal current year, implying an average EPS of $3.07. EPS for the following year is $3.14, with 23.0 analysts recommending between $3.44 and $2.69.
Revenue Estimates
15 analysts predict $17.1B in revenue for the current quarter. It ranges from a high estimate of $17.9B to a low estimate of $16.63B. As of the current estimate, Pfizer Inc’s year-ago sales were $17.7BFor the next quarter, 15 analysts are estimating revenue of $17.73B. There is a high estimate of $18.56B for the next quarter, whereas the lowest estimate is $16.54B.
A total of 23 analysts have provided revenue estimates for PFE’s current fiscal year. The highest revenue estimate was $64.15B, while the lowest revenue estimate was $60.98B, resulting in an average revenue estimate of $63.15B. In the same quarter a year ago, actual revenue was $63.63BBased on 22 analysts’ estimates, the company’s revenue will be $62.75B in the next fiscal year. The high estimate is $65.41B and the low estimate is $59.18B.
